Gliomas and solid tumours such as gastrointestinal tumours
Conditions
Interventions
Index test:68Ga-FAPI-Var3 PET/CT
Sponsors
The First Affiliated Hospital of the People's Liberation Army Air Force Military Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >=18 years old; 2. Patients pathologically diagnosed with gastrointestinal glioma and solid tumors in the gastrointestinal tract, as well as those scheduled for surgical resection or exploration (including primary or recurrent metastatic tumors); 3. As judged by a doctor, the expected survival period is more than 3 months; 4. Voluntarily sign the informed consent form; Willing and able to follow the research plan.
Exclusion criteria
Exclusion criteria: 1. Those with a history of allergy to 68Ga-FAPI-Var3 or its excipients; 2. People allergic to alcohol; 3. Those who cannot tolerate intravenous administration (such as those with a history of fainting at the sight of needles or blood); 4. Those who are not suitable for or unable to complete imaging examinations such as PET due to special reasons, including those with claustrophobia, radiophobia, etc. 5. Pregnant and lactating women; 6. Practitioners who need to be exposed to radioactive conditions for a long time; 7. Suffering from serious diseases of the heart, kidneys, lungs, blood vessels, nerves, mental system, etc., immune deficiency diseases and hepatitis/liver cirrhosis; 8. Have participated in other interventional clinical trials within one month prior to screening; 9. There are other circumstances that the researcher deems unsuitable for participation in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The maximum standardized uptake value;Average standardized uptake value; | — |
Countries
China
Contacts
Public ContactWeidong Yang
the First Affiliated Hospital of the People's Liberation Army Air Force Military Medical University
Outcome results
None listed